Cysteine derivative · Fact sheet

N-acetylcysteine

Also known as NAC · Acetylcysteine

N-acetylcysteine has established medical uses, including the approved Acetadote product for acetaminophen poisoning. Claims about compulsive behavior, mental health, and general antioxidant wellness have separate, more limited evidence.

FDA approved for specific usesModerate human evidence

What is N-acetylcysteine?

NAC supplies cysteine involved in glutathione synthesis and has been studied in glutamate signaling. Approved medicinal formulations and consumer supplements are not interchangeable.

Benefits & claims

Liver protection, fewer compulsive urges, respiratory effects, and antioxidant support attract interest. An antidote indication cannot be generalized to routine detox or prevention.

What the evidence supports

  • Acetadote is an approved treatment to prevent or lessen liver injury after potentially toxic acetaminophen exposure.
  • Adult hair-pulling findings did not reproduce in the pediatric trial and do not establish broad mental-health benefits.
Research areas
  • Acetaminophen poisoning
  • Trichotillomania
  • Glutathione and glutamate pathways

Dosage & frequency

Product-specific label information

Acetadote has a monitored intravenous antidote regimen for acetaminophen poisoning. This indication is separate from oral NAC supplementation or psychiatric research.

Acetadote

Adults and pediatric patients at least 5 kg with potentially hepatotoxic acetaminophen exposure

Amount
Total 300 mg/kg
Frequency
A monitored 20–21-hour treatment course
Route studied or labeled
Intravenous

Two- or three-bag protocols have different eligibility; this is an emergency antidote, not a supplement schedule.

How to read these amounts

An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.

Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences

Formulations, interactions & practical context

Formulation differences

  • Oral NAC supplements, oral antidote products, and Acetadote injection are different formulations and contexts.

Interactions & precautions

  • The intravenous antidote label does not establish a comprehensive interaction profile for long-term oral NAC supplement combinations.

What is still unresolved

  • The antidote regimen does not establish a longevity or cognitive-health schedule.

Side effects & risks

  • The Acetadote label warns about serious hypersensitivity reactions, including rash, low blood pressure, breathing difficulty, and bronchospasm.
  • Fluid overload is a formulation- and treatment-context risk described in the label. These risks should not be converted into side-effect rates for unrelated oral products.

This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.

Clinical research

Moderate human evidence

Approval evidence applies to a defined poisoning indication. A 50-adult hair-pulling trial was positive, while a 39-participant pediatric trial was not; the psychiatric evidence is preliminary and population-specific.

Studies

Personal experiences

Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.

Explore 5 sourced accounts by reported effect.

Energy: reported experiences

Negative account · personal report

Emotional flatness and less response to caffeine

An author described losing enjoyment in music and feeling flat after several weeks of NAC, with symptoms still present a week after stopping. The same account was crossposted elsewhere.

Reported use in this account

Product
Product described as NAC
Amount
Not specified clearly
Frequency
Not specified clearly
Route
Not specified clearly
Duration
About three to four weeks; stopped about one week before the report

Other exposures described: Caffeine-containing energy drinks; Prior L-glutamine reaction, not a concurrent treatment

Prior supplement reactions, caffeine use and an unverified diagnosis complicate attribution. Crossposts are one account; the suggested neurotransmitter mechanism is not established.

Read the original account
Mixed account · personal report

An early lift followed by fatigue and emotional flatness

A different author described several days of more energy and motivation, followed by fatigue, boredom and reduced enjoyment during three weeks of NAC with glycine. Changing the NAC amount reportedly did not sustain the initial benefit.

Reported use in this account

Product
NAC supplement
Amount
600 mg initially, then 1,200 mg, later back to 600 mg, as reported
Frequency
Not specified clearly
Route
Not specified clearly
Duration
Three weeks

Other exposures described: Glycine; Zinc and selenium tried later

Glycine, later mineral supplements and an unverified product complicate attribution. The account does not establish a sulfur-related mechanism or a safe exposure.

Read the account with reported amounts

Approval status

Acetadote is FDA approved to prevent or lessen liver injury after potentially hepatotoxic acetaminophen ingestion in adults and pediatric patients weighing at least 5 kg. This does not approve NAC supplements for mental-health or wellness claims.

Approved uses

  • Acetadote: prevention or reduction of liver injury after potentially toxic acetaminophen ingestion in the labeled population

Approved antidote; other claims separate

Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.

Open questions

  • Which psychiatric populations benefit reproducibly
  • Long-term wellness outcomes
  • Comparability of supplement and approved-product exposures

Summary

NAC has a clear medical role, but evidence for each additional claim must stand on its own.

Sources

Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.

  1. fdaFDA: Acetadote prescribing information

    Approved poisoning indication and product-specific warnings.

  2. pubmedNAC in adults with trichotillomania

    50-adult, 12-week placebo-controlled trial with improved hair-pulling symptoms.

  3. pubmedNAC in pediatric trichotillomania

    39 children and adolescents; no significant benefit over placebo.

How we assess sources · Suggest a correction